Investment type
- Management buyout
Prism Medical UK is the manufacturer and provider of specialist healthcare equipment in a range of care environments, including schools, hospitals and care homes. The business provides a full service that takes care of the design, installation and maintenance of its products.
It employs 450 people and has a diversified product portfolio of more than 180 products.
International acquisitive growth
In April 2014, LDC backed the management buyout of Prism to help drive growth at home and overseas. Working with CEO Stuart Meldrum and his management team, we helped the business to accelerate its buy and build strategy, increase exports and invest heavily in new product development.
This included the acquisition of four complementary businesses – HME, Smirthwaite, Mackworth and TMEC – which together strengthened Prism’s presence in the mobility and patient handling markets.
LDC have helped to guide a growth journey that has ultimately seen us expand across the UK, ramp up exports and enter new markets segments – all of which means we can bring more of our market leading products to those who need it the most.”
Over the four-year partnership with LDC, Prism launched an average of five new products a year and expanded overseas to new markets including Australia and China. When we exited the business, international sales had grown to the point where they accounted for 10 per cent of turnover.
Doubling revenues
During its four years with LDC, Prism recorded a 54 per cent increase in revenues to £40m.
LDC exited the investment in Prism in December 2018 with a sale to Limerston Capital.